Hayfin Supports Crown Lab GlaxoSmithKline Brands Acquisition

Hayfin Capital Management provided debt financing to support Crown Laboratories and Hildred Capital Partners’ acquisition of North American distribution rights of five OTC consumer brands from GlaxoSmithKline.

Hayfin Provides $27.8MM Term Loan to Sinclair Pharma

Hayfin Capital Management provided a €23 million ($27.805 million) debt facility consisting of a five-year term loan to Sinclair Pharma, an international aesthetics company.

DNB Agents $125MM Facilities to Support GulfMark Restructuring

GulfMark Offshore completed its financial restructuring plan and emerged from bankruptcy protection under Chapter 11 of the U.S. Bankruptcy Code. DNB Capital served as administrative agent for a $25 million revolver and a $100 million term loan to support the restructuring.

GB Credit Launches European Lending Platform

GB Credit Partners announced its first European transaction. The loan is part of a €75 million ($102 million) facility arranged by Hayfin Capital to ATU, and is part of a broader recapitalization between the company and its main creditors, including Centerbridge Partners and Goldman Sachs.